Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Christopher W. Szeto

机构：Exelixis (United States) · ORCID：0000-0002-2344-7716

发表论文 147 篇 · 总被引 741 次 · h-index 12

代表论文

  • Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy (2024 · Circulation Research · 被引 39)
  • Abstract 1733: XL495 is a potent, selective, and orally bioavailable inhibitor of PKMYT1 (2025 · Cancer Research · 被引 4)
  • Supplementary Data: Figures S1-S6 and Tables S1-S6 from Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial (2025)
  • Supplementary Figure S2 from Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial (2025)
  • Supplementary Figure S1 from Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial (2025)
  • Supplementary Figure S3 from Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial (2025)